Drug Approval | June 25, 2025
Lupin receives USFDA approval for Prucalopride Tablets
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
Prucalopride Tablets are indicated for the treatment of chronic idiopathic constipation in adults
This collaboration ensures that patients receive comprehensive care, including emotional and psychological support throughout their fertility journey
First and only TROP2-directed therapy approved in the US for the treatment of lung cancer
WINREVAIR significantly reduced the risk of clinical worsening events in recently diagnosed PAH patients over 70 percent of whom were on double background therapy
The transaction is expected to close in Q2 FY 2026
The company will provide the necessary response to USFDA within stipulated 15 days
BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival - three times longer than R-GemOx
The proceeds from the QIP will be utiized for purchase of outstanding optionally convertible debentures
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
Subscribe To Our Newsletter & Stay Updated
